Step 1: Anandamide, also called N-arachidonoylethanolamine (AEA), is an endogenous cannabinoid. Its name comes from the Sanskrit word ananda meaning bliss or delight, combined with amide. This identifies it as a cannabinoid neurotransmitter, so option (d) is correct.
Step 2: It is synthesised from N-arachidonoyl phosphatidylethanolamine and acts on cannabinoid receptors in the brain. It is degraded mainly by the enzyme fatty acid amide hydrolase (FAAH), which splits it into ethanolamine and arachidonic acid.
Step 3: Anandamide is not an opioid (a), not a CK1 antagonist (b), and not a dopamine D2 blocker (c). Those describe unrelated drug classes, so the only correct description is an endogenous cannabinoid neurotransmitter.